LPL Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.92M | Sell |
9,406
-7,136
| -43% | -$3.41M | ﹤0.01% | 2636 |
|
|
2025
Q4 | $9.63M | Sell |
16,542
-5,996
| -27% | -$3.06M | ﹤0.01% | 1962 |
|
|
2025
Q3 | $10.3M | Buy |
22,538
+8,417
| +60% | +$3.14M | ﹤0.01% | 1834 |
|
|
2025
Q2 | $4.27M | Sell |
14,121
-16,701
| -54% | -$4.98M | ﹤0.01% | 2446 |
|
|
2025
Q1 | $10.2M | Buy |
30,822
+25,602
| +490% | +$8.41M | ﹤0.01% | 1588 |
|
|
2024
Q4 | $1.61M | Buy |
5,220
+480
| +10% | +$135K | ﹤0.01% | 3064 |
|
|
2024
Q3 | $1.01M | Sell |
4,740
-438
| -8% | -$112K | ﹤0.01% | 3397 |
|
|
2024
Q2 | $1.45M | Buy |
5,178
+1,749
| +51% | +$416K | ﹤0.01% | 2905 |
|
|
2024
Q1 | $916K | Sell |
3,429
-143
| -4% | -$33.7K | ﹤0.01% | 3265 |
|
|
2023
Q4 | $826K | Buy |
+3,572
| New | +$625K | ﹤0.01% | 3216 |
|
|
2023
Q3 | – | Sell |
-1,010
| Closed | -$233K | – | 4753 |
|
|
2023
Q2 | $233K | Buy |
1,010
+184
| +22% | +$49.8K | ﹤0.01% | 4042 |
|
|
2023
Q1 | $200K | Sell |
826
-57
| -6% | -$15.5K | ﹤0.01% | 4048 |
|
|
2022
Q4 | $256K | Buy |
+883
| New | +$86.4K | ﹤0.01% | 3791 |
|
|
2022
Q2 | – | Sell |
-3,768
| Closed | -$370K | – | 4499 |
|
|
2022
Q1 | $370K | Buy |
+3,768
| New | +$318K | ﹤0.01% | 3412 |
|
|
2021
Q4 | – | Sell |
-2,813
| Closed | -$224K | – | 4411 |
|
|
2021
Q3 | $224K | Sell |
2,813
-205
| -7% | -$17.7K | ﹤0.01% | 3881 |
|
|
2021
Q2 | $294K | Buy |
3,018
+675
| +29% | +$79.9K | ﹤0.01% | 3603 |
|
|
2021
Q1 | $274K | Buy |
+2,343
| New | +$273K | ﹤0.01% | 3543 |
|
|
2019
Q1 | – | Sell |
-2,260
| Closed | -$255K | – | 3225 |
|
|
2018
Q4 | $255K | Buy |
2,260
+947
| +72% | +$147K | ﹤0.01% | 2593 |
|
|
2018
Q3 | $281K | Sell |
1,313
-10
| -0.8% | -$2.51K | ﹤0.01% | 2755 |
|
|
2018
Q2 | $370K | Buy |
+1,323
| New | +$232K | ﹤0.01% | 2459 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
